Quest Diagnostics (DGX) Tops Q1 EPS by 6c
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $247.45 +0.15%
EPS Growth %: +10.0%
Financial Fact:
Less: Net income attributable to noncontrolling interests: 13M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +10.0%
Financial Fact:
Less: Net income attributable to noncontrolling interests: 13M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $2.04, $0.06 better than the analyst estimate of $1.98. Revenue for the quarter came in at $2.33 billion versus the consensus estimate of $2.2 billion.
GUIDANCE:
Quest Diagnostics sees Q2 2023 EPS of $8.45-$8.95, versus the consensus of $8.71. Quest Diagnostics sees Q2 2023 revenue of $8.93-9.08 billion, versus the consensus of $8.98 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Gartner places F5 in AI application security emerging market report
- Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
